A ribonuclease protection assay for the direct detection and quantitation of hepatitis C virus RNA

Nafees - Ahmad, I. Ken Kuramoto, Bahige M. Baroudy

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

A ribonuclease protection assay (RPA) was developed for the direct detection and quantitation of HCV RNA in infected patients' sera or plasma using HCV [32P]RNA from the conserved 5′-untranslated region (5′-UTR) as a probe. We were able to directly detect the presence of HCV RNA by RPA in several infected patients' samples. The viremic status of HCV infected patients with indeterminate recombinant immunoblot assay (RIBA II) was also determined by this assay. Polymerase chain reaction (PCR) was also performed on all these samples and were found to be positive with a concordance of 100% between the results of PCR and RPA. The RPA was able to detect approximately 1 pg of HCV RNA. A limited sequence heterogeneity among HCV isolates was also observed by this assay, suggesting that this may be a faster method of detecting heterogeneous HCV sequences in patients' samples. This simple and specific method could be used to quantitate HCV RNA in order to better determine viremia and follow the course of HCV infection especially when RIBA II results are indeterminate.

Original languageEnglish (US)
Pages (from-to)233-244
Number of pages12
JournalClinical and Diagnostic Virology
Volume1
Issue number4
DOIs
StatePublished - Jan 1 1993
Externally publishedYes

Fingerprint

Ribonucleases
Hepacivirus
RNA
Polymerase Chain Reaction
5' Untranslated Regions
Viremia
Infection
Serum

Keywords

  • 5′-Untranslated region
  • HCV
  • Polymerase chain reaction
  • Ribonuclease protection assay
  • Viremia

ASJC Scopus subject areas

  • Virology

Cite this

A ribonuclease protection assay for the direct detection and quantitation of hepatitis C virus RNA. / Ahmad, Nafees -; Kuramoto, I. Ken; Baroudy, Bahige M.

In: Clinical and Diagnostic Virology, Vol. 1, No. 4, 01.01.1993, p. 233-244.

Research output: Contribution to journalArticle

@article{61725747f18b4e42a234d58dd597cc29,
title = "A ribonuclease protection assay for the direct detection and quantitation of hepatitis C virus RNA",
abstract = "A ribonuclease protection assay (RPA) was developed for the direct detection and quantitation of HCV RNA in infected patients' sera or plasma using HCV [32P]RNA from the conserved 5′-untranslated region (5′-UTR) as a probe. We were able to directly detect the presence of HCV RNA by RPA in several infected patients' samples. The viremic status of HCV infected patients with indeterminate recombinant immunoblot assay (RIBA II) was also determined by this assay. Polymerase chain reaction (PCR) was also performed on all these samples and were found to be positive with a concordance of 100{\%} between the results of PCR and RPA. The RPA was able to detect approximately 1 pg of HCV RNA. A limited sequence heterogeneity among HCV isolates was also observed by this assay, suggesting that this may be a faster method of detecting heterogeneous HCV sequences in patients' samples. This simple and specific method could be used to quantitate HCV RNA in order to better determine viremia and follow the course of HCV infection especially when RIBA II results are indeterminate.",
keywords = "5′-Untranslated region, HCV, Polymerase chain reaction, Ribonuclease protection assay, Viremia",
author = "Ahmad, {Nafees -} and Kuramoto, {I. Ken} and Baroudy, {Bahige M.}",
year = "1993",
month = "1",
day = "1",
doi = "10.1016/0928-0197(93)90005-P",
language = "English (US)",
volume = "1",
pages = "233--244",
journal = "Journal of Clinical Virology",
issn = "1386-6532",
publisher = "Elsevier",
number = "4",

}

TY - JOUR

T1 - A ribonuclease protection assay for the direct detection and quantitation of hepatitis C virus RNA

AU - Ahmad, Nafees -

AU - Kuramoto, I. Ken

AU - Baroudy, Bahige M.

PY - 1993/1/1

Y1 - 1993/1/1

N2 - A ribonuclease protection assay (RPA) was developed for the direct detection and quantitation of HCV RNA in infected patients' sera or plasma using HCV [32P]RNA from the conserved 5′-untranslated region (5′-UTR) as a probe. We were able to directly detect the presence of HCV RNA by RPA in several infected patients' samples. The viremic status of HCV infected patients with indeterminate recombinant immunoblot assay (RIBA II) was also determined by this assay. Polymerase chain reaction (PCR) was also performed on all these samples and were found to be positive with a concordance of 100% between the results of PCR and RPA. The RPA was able to detect approximately 1 pg of HCV RNA. A limited sequence heterogeneity among HCV isolates was also observed by this assay, suggesting that this may be a faster method of detecting heterogeneous HCV sequences in patients' samples. This simple and specific method could be used to quantitate HCV RNA in order to better determine viremia and follow the course of HCV infection especially when RIBA II results are indeterminate.

AB - A ribonuclease protection assay (RPA) was developed for the direct detection and quantitation of HCV RNA in infected patients' sera or plasma using HCV [32P]RNA from the conserved 5′-untranslated region (5′-UTR) as a probe. We were able to directly detect the presence of HCV RNA by RPA in several infected patients' samples. The viremic status of HCV infected patients with indeterminate recombinant immunoblot assay (RIBA II) was also determined by this assay. Polymerase chain reaction (PCR) was also performed on all these samples and were found to be positive with a concordance of 100% between the results of PCR and RPA. The RPA was able to detect approximately 1 pg of HCV RNA. A limited sequence heterogeneity among HCV isolates was also observed by this assay, suggesting that this may be a faster method of detecting heterogeneous HCV sequences in patients' samples. This simple and specific method could be used to quantitate HCV RNA in order to better determine viremia and follow the course of HCV infection especially when RIBA II results are indeterminate.

KW - 5′-Untranslated region

KW - HCV

KW - Polymerase chain reaction

KW - Ribonuclease protection assay

KW - Viremia

UR - http://www.scopus.com/inward/record.url?scp=38248999671&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=38248999671&partnerID=8YFLogxK

U2 - 10.1016/0928-0197(93)90005-P

DO - 10.1016/0928-0197(93)90005-P

M3 - Article

C2 - 15566737

AN - SCOPUS:38248999671

VL - 1

SP - 233

EP - 244

JO - Journal of Clinical Virology

JF - Journal of Clinical Virology

SN - 1386-6532

IS - 4

ER -